Brief: Aurobindo Pharma Says U.S. FDA Inspection At Unit-Iv Of Apitoria Pharma Private Completed
11/09/2026 13:47
BRIEF-Aurobindo Pharma Says U.S. FDA Inspection At Unit-Iv Of Apitoria Pharma Private Completed Sept 11 (Reuters) - Aurobindo Pharma Limited ARBN.NS:
COMPLETION OF US FDA INSPECTION AT UNIT-IV OF APITORIA PHARMA PRIVATE
INSPECTION CONCLUDED WITH ZERO OBSERVATIONS
Further company coverage: ARBN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11